SEARCH

SEARCH BY CITATION

References

  • Bellosillo, B., Colomer, D., Pons, G. & Gil, J. (1998) Mitoxantrone, a topoisomerase II inhibitor, induces apoptosis of B-chronic lymphocytic leukaemia cells. British Journal of Haematology, 100, 142146.
  • Bellosillo, B., Villamor, N., Colomer, D., Pons, G., Montserrat, E. & Gil, J. (1999) In vitro evaluation of fludarabine in combination with cyclophosphamide and/or mitoxantrone in B-cell chronic lymphocytic leukemia. Blood, 94, 28362843.
  • Cheson, B.D. (1996) Chronic lymphoid leukemias. Clinical Oncology (ed. by M.D.Abeloff, J.O.Armitage, A.S.Lichter & J.E.Niederhuber), pp. 19992021. Churchill Livingstone, New York.
  • Cheson, B.D., Bennett, J.M., Grever, M., Kay, N., Keating, M.J., O'Brien, S. & Rai, K.R. (1996) National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood, 87, 499049973.
  • Cheson, B.D., Vena, D.A., Barrett, J. & Freidlin, B. (1999) Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias. Journal of Clinical Oncology, 17, 24542460.
  • Clavio, M., Miglino, M., Spriano, M., Pietrasanta, D., Vallebella, E., Celesti, L., Canepa, L., Pierri, I., Cavaliere, M., Ballerini, F., Beltrami, G., Rossi, E., Vimercati, R., Bruni, R., Congiu, M., Nati, S., Damasio, E., Santini, G. & Gobbi, M. (1998) First line fludarabine treatment of symptomatic chronic lymphoproliferative diseases: clinical results and molecular analysis of minimal residual disease. European Journal of Haematology, 61, 197203.
  • Elias, L., Stock-Novack, D., Head, D.R., Grever, M.R., Weick, J.K., Chapman, R.A., Godwin, J.E., Metz, E.N. & Appelbaum, F.R. (1993) A phase I trial of combination fludarabine monophosphate and chlorambucil in chronic lymphocytic leukemia: a Southwest Oncology Group study. Leukemia, 7, 361365.
  • Esteve, J., Villamor, N., Colomer, D., Cervantes, F., Campo, E., Carreras, E. & Montserrat, E. (2001) Stem cell transplantation for chronic lymphocytic leukemia: different outcome after autologous and allogeneic transplantation and correlation with minimal residual disease status. Leukemia, 15, 445451.
  • Flinn, I.W., Byrd, J.C., Morrison, C., Jamison, J., Diehl, L.F., Murphy, T., Piantadosi, S., Seifter, E., Ambinder, R.F., Vogelsang, G. & Grever, M.R. (2000) Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignancies. Blood, 96, 7175.
  • French Cooperative Group on Chronic Lymphocytic Leukaemia. (1986) Effectiveness of ‘CHOP’ regimen in advanced untreated chronic lymphocytic leukaemia. French Cooperative Group on Chronic Lymphocytic Leukaemia. Lancet, 1, 13461349.
  • Frewin, R., Turner, D., Tighe, M., Davies, S., Rule, S. & Johnson, S. (1999) Combination therapy with fludarabine and cyclophosphamide as salvage treatment in lymphoproliferative disorders. British Journal of Haematology, 104, 612613.
  • Gale, R.P., Caligaris-Cappio, F., Dighiero, G., Keating, M., Montserrat, E. & Rai, K. (1994) Recent progress in chronic lymphocytic leukemia. International Workshop on chronic Lymphocytic Leukemia. Leukemia, 8, 16101614.
  • Gandhi, V., Robertson, L.E., Keating, M.J. & Plunkett, W. (1994) Combination of fludarabine and arabinosylcytosine for treatment of chronic lymphocytic leukemia: clinical efficacy and modulation of arabinosylcytosine pharmacology. Cancer Chemotherapy and Pharmacology, 34, 3036.
  • Hallek, M., Schmitt, B., Wilhelm, M., Busch, R., Krober, A., Fostitsch, H.P., Sezer, O., Herold, M., Knauf, W., Wendtner, C.M., Kuse, R., Freund, M., Franke, A., Schriever, F., Nerl, C., Dohner, H., Thiel, E., Hiddemann, W., Brittinger, G. & Emmerich, B. (2001) Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study Group. British Journal of Haematology, 114, 342348.
  • Johnson, S., Smith, A.G., Loffler, H., Osby, E., Juliusson, G., Emmerich, B., Wyld, P.J. & Hiddemann, W. (1996) Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLL. Lancet, 347, 14321438.
  • Kaplan, E.L. & Meier, P. (1958) Non-parametric estimation from incomplete observations. Journal of American Statistical Association, 53, 457481.
  • Keating, M.J., O'Brien, S., Kantarjian, H., Plunkett, W., Estey, E., Koller, C., Beran, M. & Freireich, E.J. (1993) Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent. Blood, 81, 28782884.
  • Kempin, S., Lee, III, B.J. Thaler, H.T., Koziner, B., Hecht, S., Gee, T., Arlin, Z., Little, C., Straus, D., Reich, L., Phillips, E., Al Mondhiry, H., Dowling, M., Mayer, K. & Clarkson, B. (1982) Combination chemotherapy of advanced chronic lymphocytic leukemia: the M-2 protocol (vincristine, BCNU, cyclophosphamide, melphalan, and prednisone). Blood, 60, 11101121.
  • Leporrier, M., Chevret, S., Cazin, B., Boudjerra, N., Feugier, P., Desablens, B., Rapp, M.J., Jaubert, J., Autrand, C., Divine, M., Dreyfus, B., Maloum, K., Travade, P., Dighiero, G., Binet, J.L. & Chastang, C. (2001) Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients. Blood, 98, 23192325.
  • McLaughlin, P., Hagemeister, F.B., Romaguera, J.E., Sarris, A.H., Pate, O., Younes, A., Swan, F., Keating, M. & Cabanillas, F. (1996) Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma. Journal of Clinical Oncology, 14, 12621268.
  • Mantel, N. (1966) Evaluation of survival data and two new rank order statistics arising to consideration. Cancer Chemotherapy Report, 50, 163170.
  • Marotta, G., Bigazzi, C., Lenoci, M., Tozzi, M., Bocchia, M. & Lauria, F. (2000) Low-dose fludarabine and cyclophosphamide in elderly patients with B-cell chronic lymphocytic leukemia refractory to conventional therapy. Haematologica, 85, 12681270.
  • Montserrat, E., Lopez-Lorenzo, J.L., Manso, F., Martin, A., Prieto, E., Arias-Sampedro, J., Fernandez, M.N., Oyarzabal, F.J., Odriozola, J., Alcala, A., Garcia-Conde, J., Guardia, R. & Bosch, F. (1996) Fludarabine in resistant or relapsing B-cell chronic lymphocytic leukemia: the Spanish Group experience. Leukaemia and Lymphoma, 21, 467472.
  • Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods, 65, 5563.
  • Noy, A., Verma, R., Glenn, M., Maslak, P., Rahman, Z.U., Keenan, J.R., Weiss, M., Filippa, D. & Zelenetz, A.D. (2001) Clonotypic polymerase chain reaction confirms minimal residual disease in CLL nodular PR: results from a sequential treatment CLL protocol. Blood, 97, 19291936.
  • O'Brien, S.M., Kantarjian, H.M., Cortes, J., Beran, M., Koller, C.A., Giles, F.J., Lerner, S. & Keating, M. (2001) Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia. Journal of Clinical Oncology, 19, 14141420.
  • Provan, D., Bartlett-Pandite, L., Zwicky, C., Neuberg, D., Maddocks, A., Corradini, P., Soiffer, R., Ritz, J., Nadler, L.M. & Gribben, J.G. (1996) Eradication of polymerase chain reaction-detectable chronic lymphocytic leukemia cells is associated with improved outcome after bone marrow transplantation. Blood, 88, 22282235.
  • Rai, K.R., Peterson, B.L., Appelbaum, F.R., Kolitz, J., Elias, L., Shepherd, L., Hines, J., Threatte, G.A., Larson, R.A., Cheson, B.D. & Schiffer, C.A. (2000) Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia. New England Journal of Medicine, 343, 17501757.
  • Robak, T., Blonski, J.Z. & Kasznicki, M. (2001) Does intensive treatment with high dose chlorambucil and prednisone as first line and cladribine as second line influence the survival of the patients with chronic lymphocytic leukemia? Leukaemia and Lymphoma, 41, 545557.
  • Robertson, L.E., Huh, Y.O., Butler, J.J., Pugh, W.C., Hirsch-Ginsberg, C., Stass, S., Kantarjian, H. & Keating, M.J. (1992) Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: clinical, pathologic, immunophenotypic, and molecular analysis. Blood, 80, 2936.
  • Robertson, L.E., O'Brien, S., Kantarjian, H., Koller, C., Beran, M., Andreeff, M., Lerner, S. & Keating, M.J. (1995) Fludarabine plus doxorubicin in previously treated chronic lymphocytic leukemia. Leukemia, 9, 943945.
  • Rozman, C. & Montserrat, E. (1995) Chronic lymphocytic leukemia. New England Journal of Medicine, 333, 10521057.
  • Rummel, M.J., Kafer, G., Pfreundschuh, M., Jager, E., Reinhardt, U., Mitrou, P.S., Hoelzer, D. & Bergmann, L. (1999) Fludarabine and epirubicin in the treatment of chronic lymphocytic leukaemia: a German multicenter phase II study. Annals of Oncology, 10, 183188.
  • Sala, R., Mauro, F.R., Bellucci, R., De Propris, M.S., Cordone, I., Lisci, A., Foa, R. & De Fabritiis, P. (1998) Evaluation of marrow and blood haemopoietic progenitors in chronic lymphocytic leukaemia before and after chemotherapy. European Journal of Haematology, 61, 1420.
  • Sorensen, J.M., Vena, D.A., Fallavollita, A., Chun, H.G. & Cheson, B.D. (1997) Treatment of refractory chronic lymphocytic leukemia with fludarabine phosphate via the group C protocol mechanism of the National Cancer Institute: five-year follow-up report. Journal of Clinical Oncology, 15, 458465.
  • Weiss, M., Spiess, T., Berman, E. & Kempin, S. (1994) Concomitant administration of chlorambucil limits dose intensity of fludarabine in previously treated patients with chronic lymphocytic leukemia. Leukemia, 8, 12901293.
  • Zaja, F., Rogato, A., Russo, D., Marin, L., Silvestri, F. & Baccarani, M. (1997) Combined therapy with fludarabine and cyclophosphamide in relapsed/resistant patients with B-cell chronic lymphocytic leukaemia and non-Hodgkin's lymphomas. European Journal of Haematology, 59, 327328.
  • Zinzani, P.L., Lauria, F., Rondelli, D., Benfenati, D., Raspadori, D., Bocchia, M., Gozzetti, A., Cavo, M., Cirio, T.M., Zaja, F., Russo, D., Fanin, R., Galieni, P., Algeri, R., Fiacchini, M. & Tura, S. (1993) Fludarabine in patients with advanced and/or resistant B-chronic lymphocytic leukemia. European Journal of Haematology, 51, 9397.